Atlas Trials

Lenalidomide Maintenance Therapy in Patients With Myelodysplastic Syndromes (MDS) or Acute Myelogenous Leukemia (AML)

Clinical trial NCT00720850 · TERMINATED

Trial details

NCT number
NCT00720850
Sponsor
Technische Universität Dresden
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Myelodysplastic SyndromesAcute Myelogenous Leukemia
Start date
2008-04-01
Primary completion
2011-01-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.